Chlorella
Chlorella scored 6.5 / 10 (👍 Worth trying) on the BioHarmony scale as a Substance → Vitamin / Mineral / Nutrient.
Chlorella is an edible freshwater green microalga used as a whole-food supplement. The best-supported human effects are modest cardiovascular ones: a meta-analysis of 19 RCTs (n=797) by Fallah 2018 found total cholesterol fell 9.09 mg/dL, LDL fell 8.32 mg/dL, and systolic blood pressure fell 4.51 mmHg, with a clean safety profile. Evidence is real but heterogeneous, so it earns 6.5/10, worth trying.
What is Chlorella?
Chlorella is an edible single-celled freshwater green microalga, sold as a green powder or pressed tablets and treated as a whole-food supplement rather than an isolated drug. The species you will see are usually Chlorella vulgaris or Chlorella pyrenoidosa. Its appeal is that it packs a lot into a cheap, clean package: roughly 45 to 60 percent protein by dry weight, plus chlorophyll, beta-carotene, lutein, iron, and a chlorella-specific bioactive fraction marketers call chlorella growth factor. The best-documented human benefits are modest cardiovascular ones, with Fallah 2018 pooling 19 randomized trials and finding small but real drops in cholesterol and blood pressure. The score sits at worth-trying because the effects are genuine and the downside is almost nonexistent, but the magnitude is gentle and the evidence is heterogeneous.
Mechanistically, chlorella acts like a food, not a single molecule. Soluble fiber and plant sterols reduce cholesterol absorption, the rigid cell wall and chlorophyll bind fat-soluble toxins in the gut, and the carotenoid and micronutrient load supports antioxidant and immune endpoints. One practical note shapes everything: the natural cell wall is hard to digest, so cracked-cell-wall or broken-cell-wall product is the sensible default, and a published heavy-metal certificate of analysis matters because algae can concentrate whatever is in their water.
Terminology
Chlorella sits at the intersection of food and supplement marketing, so a few terms decide whether you read a claim correctly. The most important distinctions are the species you are buying, what cracked cell wall actually means for absorption, and why detox is a slippery word here. Get those three right and most chlorella marketing becomes easy to parse.
- Chlorella vulgaris / Chlorella pyrenoidosa: The two species used in nearly all human studies. They are broadly interchangeable for the cardiovascular and liver findings.
- Cracked cell wall (broken cell wall): Processing that fractures the tough natural cell wall so nutrients are digestible. Intact-cell chlorella absorbs poorly, so this is the practical default.
- CGF (chlorella growth factor): A marketed nutrient fraction from chlorella's nucleotide-rich extract. Real as a compositional feature, but not a proven standalone therapeutic.
- NAFLD: Non-alcoholic fatty liver disease, the condition in the strongest liver-enzyme trial.
- AST / ALT: Aspartate and alanine aminotransferase, liver enzymes that fall modestly in some chlorella trials.
- NK cells: Natural killer cells, an immune cell type whose activity rose in a small chlorella trial.
- Toxic equivalents (TEQ): A way to express combined dioxin toxicity, the endpoint that fell in the breast-milk study.
- Certificate of analysis (COA): A lab report confirming heavy-metal levels in a specific product batch. The single most useful document when buying chlorella.
How do you take Chlorella?
Dosing & Protocols
Dosing information is summarized from published research and community reports. This is not a prescribing guide. Consult a healthcare provider before starting any protocol.
Routes & Forms
| Route | Form | Clinical Range | Community Range |
|---|---|---|---|
| Oral tablets / pressed pellets (cracked cell wall) | Compressed cracked-cell-wall tablets | 3-10 g/day | 3-15 g/day |
| Oral powder (cracked cell wall) | Loose green powder blended into water or smoothies | 3-10 g/day | 3-15 g/day |
Protocols
Cardiovascular / lipid support Clinical
- Dose
- 5-10 g/day
- Frequency
- Daily, divided with meals
- Duration
- 8-12 weeks before judging by a lipid panel
Mirrors the dose range pooled in Fallah 2018. Treat it as an adjunct to diet, not a statin substitute.
Liver-enzyme / NAFLD adjunct Clinical
- Dose
- 1.2-1.5 g/day
- Frequency
- Daily with meals
- Duration
- 8 weeks
Reflects the Ebrahimi-Mameghani 2014 NAFLD protocol; often studied alongside vitamin E and lifestyle change, not as a standalone cure.
How this score is calculated →
What are the benefits of Chlorella?
Upside contribution: 2.00
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Efficacy | 25% | 3.0 | 0.750 | |
| Breadth | 15% | 3.5 | 0.525 | |
| Evidence | 25% | 2.9 | 0.725 | |
| Speed | 10% | 2.6 | 0.260 | |
| Durability | 10% | 2.4 | 0.240 | |
| Bioindividuality | 15% | 3.3 | 0.495 | |
| Total | 2.995 |
Upside Rationale
The upside is a broad, gentle one rather than a single dramatic effect. The strongest benefit cluster is cardiovascular, supported by a 19-trial meta-analysis showing modest cholesterol and blood-pressure reductions, and the human-evidence base most worth quoting is Fallah 2018. The key boundary condition is magnitude: every confirmed effect is small, the scale of a good whole food, not a pharmaceutical. That is exactly why chlorella deserves a fair hearing against heavily-marketed drugs, since it delivers real, broad, low-risk benefit at a fraction of the cost and conflict, even if no single endpoint is large.
Efficacy (3.0/5.0): The single strongest finding is from Fallah 2018, a meta-analysis of 19 RCTs (n=797): total cholesterol fell 9.09 mg/dL, LDL fell 8.32 mg/dL, systolic blood pressure fell 4.51 mmHg, and fasting glucose fell 4.23 mg/dL, all statistically significant. In NAFLD patients, Ebrahimi-Mameghani 2014 saw ALT drop 13.2 IU/L over 8 weeks. These are real, replicated, clinically meaningful nudges across several systems, which is why efficacy lands at a solid mid-range 3.0. It is held there, not higher, by honest magnitude: the effects are small per endpoint, one 2025 review found them neutral, and chlorella does not produce a large, unmistakable response in any single use case.
Breadth of Benefits (3.5/5.0): Chlorella touches an unusually wide set of systems for a single cheap food, which is the heart of its case. Cardiovascular: lower cholesterol and systolic pressure per Fallah 2018. Hepatic: reduced AST across 8 trials per Yarmohammadi 2021. Immune: higher NK-cell activity and salivary IgA in small trials. Toxin handling: lower breast-milk dioxin per Nakano 2007. Nutritional: lower methylmalonic acid in vegans, hinting at usable B12. That spread of plausibly-linked endpoints earns a 3.5. The scope boundary is that each individual benefit is modest and several rest on single small studies, so breadth is genuine but shallow.
Evidence Quality (2.9/5.0): The evidence base is several non-Cochrane systematic reviews and meta-analyses plus a scatter of small RCTs, with no Cochrane review and no large definitive trial. The cardiovascular and liver endpoints have pooled RCT support, which is real strength, but the trials are mostly small, short, and heterogeneous, and Pinto-Leite 2025 found a neutral cardiovascular pool. Because chlorella is a cheap, non-patentable whole food, it will never attract industry-funded mega-trials, so it should not be docked merely for lacking them. The 2.9 reflects a moderate, mixed but real signal, deliberately not crushed for the absence of pharma-scale RCTs that this kind of intervention is never going to get.
Speed of Onset (2.6/5.0): Chlorella has no acute effect, so onset is measured in weeks. The lipid and blood-pressure changes in Fallah 2018 accrued over roughly 4 to 12 weeks, liver-enzyme trials ran about 8 weeks, and immune-marker studies needed 4 to 8 weeks. The only same-day sign is green stool, which simply confirms intake. A 2.6 reflects a slow, chronic-use benefit profile: nothing you feel quickly, everything you confirm with bloodwork after a couple of months of consistent dosing.
Durability (2.4/5.0): The cardiometabolic effects appear to depend on continued intake, in the manner of a fiber-and-sterol food: stop taking it and cholesterol drifts back toward baseline rather than holding a new set point. No trials demonstrate a durable washout-resistant benefit, and no rebound or worsening beyond baseline has been reported either. The 2.4 reflects an effect that is real while you take it but not self-sustaining, which is typical of a dietary intervention rather than a drug with lasting receptor-level change.
Bioindividuality Upside (3.3/5.0): Chlorella's broad nutrient profile makes it a better bet for some people than others, which is a genuine upside for the right responder. The strongest responder profiles are people with poor baseline diets, borderline lipids, or restricted eating patterns: vegans and vegetarians showed lower methylmalonic acid in Merchant 2015, implying real nutritional benefit where a B12 or iron gap exists. Weak responders are people already eating a nutrient-dense diet with healthy lipids, for whom the marginal gain is small. There is no validated genetic predictor, but baseline status, diet quality, and existing deficiencies are reasonable real-world predictors, which supports a 3.3.
What are the risks & downsides of Chlorella?
Downside contribution: 0.82 (safety risks weighted extra)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Safety | 30% | 1.7 | 0.510 | |
| Side effects | 15% | 1.8 | 0.270 | |
| Cost | 5% | 1.8 | 0.090 | |
| Effort | 5% | 1.6 | 0.080 | |
| Opportunity | 5% | 2.2 | 0.110 | |
| Dependency | 15% | 1.4 | 0.210 | |
| Reversibility | 25% | 1.4 | 0.350 | |
| Total | 1.620 | |||
| Harm subtotal × 1.4 | 1.876 | |||
| Opportunity subtotal × 1.0 | 0.280 | |||
| Combined downside | 2.156 | |||
| Baseline offset (constant) | −1.340 | |||
| Effective downside penalty | 0.816 |
Downside Rationale
The downside is genuinely small, which is most of why a modest-efficacy whole food still scores worth-trying. There is no dominant intrinsic risk cluster: chlorella is non-toxic at normal doses, cheap, easy to take, and cleanly reversible. The one real-world hazard, heavy-metal contamination, is extrinsic to the food itself, a sourcing-quality problem solved by buying tested product, so per the scoring rules it sits as a Verdict caveat rather than inflating the Safety dimension. The people most exposed to any downside are those who buy the cheapest untested powder, take a blood thinner, or expect dramatic results and waste months on a gentle nudge.
Safety Risk (1.7/5.0): Chlorella has low intrinsic toxicity. It is a food eaten daily by millions across East Asia for decades, and the largest immune RCT, Halperin 2003, reported it was well tolerated with no serious adverse events. There is no organ-toxicity signal, no catastrophic-risk floor, and no FAERS-scale safety problem for properly-sourced product at normal doses. The genuinely-low 1.7 is scored at a clean-sourced, correctly-dosed baseline, as the rubric requires. The well-known heavy-metal contamination concern is extrinsic, a property of bad sourcing rather than of chlorella itself, so it is surfaced as a sourcing caveat in the Verdict and does not drive this dimension upward.
Side Effect Profile (1.8/5.0): The side effects are mild, common, and reversible. The most frequent are gastrointestinal in the first week or two: gas, bloating, or looser stool as the gut adjusts to the fiber load, usually settling with food and a slower ramp. Green stool from chlorophyll is universal and harmless. Rare photosensitivity, a sun-triggered skin reaction, has been reported in susceptible people and is the one effect worth stopping for. None of these are dangerous or persistent, which places the side-effect burden very low at 1.8, essentially the profile of adding a high-fiber green food to the diet.
Financial Cost (1.8/5.0): Chlorella is among the cheapest supplements per gram, roughly $10 to $25 per month at 5 g per day for quality cracked-cell-wall product. There is no meaningful brand-versus-generic premium beyond paying a little more for verified low-heavy-metal sourcing, which is money well spent. The low 1.8 reflects a near-trivial financial barrier.
Time/Effort Burden (1.6/5.0): Effort is minimal: swallow a few tablets or stir a scoop of powder into water with meals, once or twice a day. No cycling, no timing complexity, no preparation beyond tolerating the grassy taste of the powder form. The 1.6 reflects an intervention that fits into any routine with almost no friction.
Opportunity Cost (2.2/5.0): The modest opportunity cost is the risk of treating a gentle nudge as a solution. Someone with genuinely high cholesterol or hypertension who leans on chlorella instead of diet change, exercise, or indicated medication could delay a more effective intervention. It stacks cleanly with almost everything and crowds out nothing pharmacologically, so the only real cost is misplaced expectation. The 2.2 captures that opportunity-cost risk: low in absolute terms, but worth naming because the marketing oversells it.
Dependency/Withdrawal (1.4/5.0): There is no dependency, tolerance, or withdrawal syndrome. Chlorella is a food, and stopping it produces nothing beyond a gradual return of cholesterol toward baseline, which is a loss of benefit, not a withdrawal effect. The 1.4 reflects essentially zero dependency risk.
Reversibility (1.4/5.0): Stopping chlorella is clean and immediate. There are no lasting physiological changes, no taper requirement, and no irreversible effects; green stool resolves within a day or two and cardiometabolic markers simply drift back to baseline. The 1.4 reflects a fully reversible, no-consequences stop.
Is Chlorella worth it?
Chlorella is a worth-trying whole-food supplement at 6.5/10: a cheap, safe, broadly nutritious green algae with real but modest human evidence for lower cholesterol, lower blood pressure, and improved liver enzymes. It deserves to sit a notch above heavily-marketed metabolic drugs precisely because it delivers honest, low-risk, broad benefit without the industry-funded, endpoint-narrow evidence base those products lean on. The tier is justified by the evidence-risk balance: the benefits are genuine and replicated but small, and the downside is close to zero for anyone who buys tested product. The single most important practical point is sourcing, since the only real hazard, heavy-metal contamination, is a property of cheap algae, not of chlorella itself.
✅ Best for: Budget-conscious people who want a clean, broad-spectrum nutritional green with almost no downside. People with borderline-high cholesterol or blood pressure looking for a gentle, food-based adjunct alongside diet and exercise. Vegans and vegetarians who may benefit from its iron and bioactive B12 fraction, as suggested by lower methylmalonic acid in Merchant 2015. Those wanting gut-level binding of fat-soluble toxins, the narrow but real effect behind Nakano 2007. Anyone who prefers a whole-food experiment they can verify with their own bloodwork over a hyped single-molecule product.
❌ Avoid if: You take warfarin, since chlorella is rich in vitamin K and can blunt that blood thinner. You have an autoimmune condition and want to avoid immune stimulation, given the NK-cell and cytokine rises in Kwak 2012. You expect a dramatic or fast effect, because every confirmed benefit is small and slow. You are unwilling to buy product with a published heavy-metal certificate of analysis, since untested algae can carry lead, cadmium, or arsenic, the one genuine real-world risk. You have genuinely high cardiovascular risk that needs proven medication rather than a gentle adjunct.
What is Chlorella best for?
The overall BioHarmony score reflects the intervention's primary evidence profile. These subratings are independent assessments per use case.
Cardiovascular: 6.5/10
Score: 6.5/10Cardiovascular is chlorella's best-evidenced use case at 6.5/10 because Fallah 2018 pooled 19 RCTs (n=797) and found total cholesterol down 9.09 mg/dL, LDL down 8.32 mg/dL, and systolic blood pressure down 4.51 mmHg, all statistically significant. The effect sizes are modest, roughly what you would expect from a fiber-and-sterol whole food rather than a drug, and one 2025 Nutrients review by Pinto-Leite found a neutral pooled result, which is why this lands worth-trying rather than higher. The honest framing: a cheap, safe nudge for borderline numbers, best judged against your own lipid panel at 8 to 12 weeks, not a statin replacement.
Metabolic Health: 6.0/10
Score: 6.0/10Chlorella earns 6.0/10 for metabolic health because the same Fallah 2018 meta-analysis reported a small fasting-glucose reduction of 4.23 mg/dL (P=0.041) alongside the lipid and blood-pressure shifts, suggesting a broad, gentle metabolic effect rather than a targeted one. The magnitude is clinically minor and the glucose finding rests on fewer trials than the lipid endpoints, so this is a supporting benefit, not a primary reason to take it. It fits best as one small lever inside a diet-and-movement program for someone with borderline metabolic markers who wants a low-risk, food-based addition and is willing to verify the effect with bloodwork.
Immune Function: 5.5/10
Score: 5.5/10Immune function lands at 5.5/10 on small but directionally positive trials. Kwak 2012 gave 5 g/day for 8 weeks (n=51) and found significantly higher natural-killer-cell activity and rises in IFN-gamma and IL-1beta, while Otsuki 2011 showed increased salivary secretory IgA. The honest counterweight is Halperin 2003, a 124-person influenza-vaccine RCT that found no overall antibody benefit, with only a younger subgroup responding. So the immune story is real at the marker level and plausible mechanistically, but it has not translated into a clear clinical outcome like fewer infections, which keeps it conditional.
Liver / Detoxification: 6.0/10
Score: 6.0/10The liver case sits at 6.0/10 because Yarmohammadi 2021 pooled 8 RCTs and found AST fell 9.15 U/L (95% CI -16.09 to -2.21), a significant signal, while ALT and ALP did not move significantly. In NAFLD specifically, Ebrahimi-Mameghani 2014 saw ALT drop 13.2 IU/L on 1.2 g/day plus vitamin E over 8 weeks. The detox framing people attach to chlorella is broader than the data: the solid part is a modest liver-enzyme improvement and gut-level toxin binding, not a whole-body cleanse. Use it as a liver-enzyme adjunct alongside lifestyle change, tracked with a panel.
Heavy Metal / Toxin Burden: 5.5/10
Score: 5.5/10Heavy-metal and toxin burden earns 5.5/10, an interesting but narrow case. The strongest human evidence is Nakano 2007, where 6 g/day of chlorella in pregnant women lowered breast-milk dioxin toxic-equivalents significantly (P=0.003) and raised milk IgA, consistent with the cell wall binding fat-soluble toxins in the gut and reducing reabsorption. That is a specific, plausible mechanism for fat-soluble pollutants, not broad chelation of stored body metals, which chlorella does not reliably do. The irony worth stating: poorly-sourced chlorella can itself carry lead and cadmium, so the detox benefit depends entirely on buying tested product.
Antioxidant / Oxidative Stress: 5.0/10
Score: 5.0/10Antioxidant support scores 5.0/10 on mechanism plus indirect human signal rather than dedicated outcome trials. Chlorella carries chlorophyll, beta-carotene, lutein, and vitamin C, and the cardiovascular meta-analysis by Fallah 2018 is consistent with reduced oxidative and inflammatory load, but few trials measure oxidative-stress endpoints directly with chlorella as the sole variable. The practical read is that the antioxidant claim is reasonable as a contributor to its broader cardiovascular and liver effects, not as a standalone reason to supplement. If antioxidant status is the goal, define one marker, such as oxidized LDL or hs-CRP, and judge chlorella against that rather than against the green color.
Blood Sugar / Glycemic Control: 5.0/10
Score: 5.0/10Blood-sugar control earns 5.0/10 because the fasting-glucose reduction in Fallah 2018 was small (4.23 mg/dL, P=0.041) and rests on fewer trials than the lipid endpoints, with no strong HbA1c or insulin-sensitivity outcome data behind it. The fiber content gives a plausible mechanism for a gentle post-meal effect, but chlorella is not a glycemic-control tool on the order of a real intervention. It belongs in the same conditional bucket as its metabolic-health case: a minor, food-based contributor worth confirming with your own fasting glucose, not something to lean on for diabetes management.
| Use Case | Score | Summary |
|---|---|---|
| ○ Energy / Fatigue | 4.5 | Some users report steadier energy on chlorella, plausibly from correcting iron, B-vitamin, or general micronutrient gaps, but there is no controlled human evidence that it raises energy as a primary effect. It is not a stimulant. |
| ○ Endurance / Cardio | 4.5 | Zempo-Miyaki 2017 saw VO2max rise from 42.1 to 44.9 mL/kg/min on a chlorella multicomponent supplement in young men, but the trial was small (n=34) and used a multi-ingredient product, so the endurance case stays modest and unconfirmed. |
| ○ Gut Health / Microbiome | 4.0 | Chlorella supplies fermentable fiber and may shift the gut environment, and its toxin-binding works at the gut level, but dedicated human microbiome outcome trials are thin. Green stool is the most reliable gut-level marker most users will notice. |
| ○ Geriatric / Aging Population | 4.0 | The clean safety profile and broad nutrient load make chlorella a reasonable food-based addition for older adults with borderline lipids, but no aging-population outcome trials specifically support it, so the case is supportive rather than proven. |
| ○ Anti-Inflammatory | 4.0 | Reductions in cardiovascular and liver markers are consistent with lower inflammatory load, but few chlorella trials measure inflammation directly as the primary endpoint, keeping this an inferred rather than demonstrated benefit. |
| ○ Body Composition / Fat Loss | 3.5 | Some cardiovascular reviews note small BMI or body-fat shifts, but there is no dedicated, adequately-powered body-composition RCT, and the protein content alone does not justify a higher score. |
| ○ Longevity / Lifespan | 3.5 | The nutrient density and modest cardiometabolic effects are longevity-adjacent, but there is no human lifespan or healthspan outcome evidence for chlorella, so this is mechanistic optimism, not data. |
| ○ Healthspan | 3.5 | As with longevity, the broad nutrient profile and gentle cardiometabolic nudges are plausibly healthspan-supportive, but no direct healthspan endpoint has been measured in chlorella trials. |
| ○ Prenatal (Maternal & Fetal Outcomes) | 3.5 | Nakano 2007 used chlorella in pregnant women and lowered breast-milk dioxin while raising IgA, but pregnancy supplementation needs clinician guidance and clean sourcing, so this stays cautious rather than a recommendation. |
Frequently Asked Questions
What is chlorella and what does it actually do?
Chlorella is an edible freshwater green microalga taken as a whole-food supplement, not a single isolated compound. It works through several gentle mechanisms at once: soluble fiber and plant sterols that lower cholesterol absorption, chlorophyll and a rigid cell wall that bind fat-soluble toxins in the gut, and a broad load of carotenoids, iron, and micronutrients. The best-documented human effects are modest cardiovascular ones per Fallah 2018: lower total cholesterol, LDL, and systolic blood pressure. Treat it as a clean nutritional addition, not a cure.
How much chlorella should I take and when?
Most human trials use 1.2 to 10 g per day, and 3 to 5 g daily with meals is a sensible starting point. The cardiovascular meta-analysis by Fallah 2018 pooled studies across roughly this range. Cracked-cell-wall tablets or powder absorb far better than intact-cell product, since the natural cell wall is hard to digest. Split the dose and take it with food to reduce the grassy aftertaste and early gas. Doses above 10 g per day add little proven benefit and raise the sourcing-quality question, so going higher is rarely worth it.
Does chlorella really lower cholesterol and blood pressure?
Yes, modestly. The strongest evidence is Fallah 2018, a meta-analysis of 19 RCTs (n=797) that found total cholesterol fell 9.09 mg/dL, LDL fell 8.32 mg/dL, and systolic blood pressure fell 4.51 mmHg. These are real but small effects, the scale of a good whole food rather than a drug, and Pinto-Leite 2025 found a neutral pooled result, so responses vary. The honest move is to check a lipid panel and home blood pressure before and after 8 to 12 weeks and judge by your own numbers.
Can chlorella detox heavy metals and toxins from your body?
Partly, and narrowly. The clearest human evidence is Nakano 2007, where 6 g per day lowered breast-milk dioxin toxic-equivalents significantly (P=0.003), consistent with the cell wall binding fat-soluble toxins in the gut and reducing reabsorption. That supports binding of fat-soluble pollutants in the digestive tract, not broad chelation of metals already stored in your tissues. Chlorella is not a substitute for medical chelation in true heavy-metal poisoning. The irony: poorly-sourced algae can itself carry lead and cadmium, so a tested product is essential.
Is chlorella safe to take long term, and what are the side effects?
Chlorella has a clean safety record at normal doses, with the most common effects being harmless and reversible: green stool from chlorophyll, mild gas, bloating, or looser stool in the first week or two, and rarely sun-triggered photosensitivity in susceptible people. The largest immune trial, Halperin 2003, reported it was well tolerated. The genuine concern is extrinsic, not intrinsic: low-quality algae can bioaccumulate lead, cadmium, and arsenic, so buy product with a current heavy-metal certificate of analysis and the safety question largely disappears.
Who should avoid chlorella or be careful with it?
Be cautious if you take warfarin, since chlorella is rich in vitamin K and can blunt that blood thinner. People with iodine sensitivity or seafood-type allergies should start low, and anyone with an autoimmune condition should be aware chlorella can stimulate immune markers like NK-cell activity per Kwak 2012. Pregnant and breastfeeding people should only use clean, tested product under clinician guidance, even though Nakano 2007 used it in pregnancy. When in doubt, the sourcing-quality issue matters more than any of these.
Chlorella vs spirulina: which one should I choose?
They overlap but differ. Chlorella is a green microalga with a rigid cell wall that binds fat-soluble toxins in the gut, the property behind Nakano 2007. Spirulina is a blue-green cyanobacterium with no true cell wall, easier to digest, and a slightly stronger blood-pressure and allergic-rhinitis evidence base. For cholesterol and gut-level toxin binding, chlorella has the edge; for blood pressure and sinus or allergy support, spirulina edges ahead. Both are cheap and safe, so the choice comes down to your target, and some people simply rotate the two.
How fast does chlorella work and when should I see results?
Think in weeks, not days. Chlorella has no acute, same-day effect, so the only quick sign you are taking it is green stool from chlorophyll. The measurable benefits build slowly: lipid and blood-pressure changes in the Fallah 2018 trials accrued over roughly 4 to 12 weeks, and liver-enzyme studies ran about 8 weeks. The practical plan is to take a consistent dose for at least 8 to 12 weeks, then recheck a lipid panel, liver enzymes, or home blood pressure, and decide based on whether your own numbers actually moved.
What could change Chlorella's score?
BioHarmony scores are living assessments. New research, regulatory changes, or personal context can shift the score up or down. These are the most likely scenarios that would change this intervention's rating.
The most plausible upgrade would come from a large, well-conducted RCT or a tighter meta-analysis confirming the cardiovascular and liver effects with less heterogeneity, which would lift Evidence and Efficacy first and could move chlorella into strong-recommend territory. The most plausible downgrade would come from a consistent body of real-world contamination failures reframing the heavy-metal issue as intrinsic rather than a sourcing problem, or from larger trials replicating the neutral Pinto-Leite result, either of which would pull Evidence and Efficacy down.
| Scenario | Dimension shifts | New Score |
|---|---|---|
| Large definitive RCT confirms lipid and BP effects with low heterogeneity | Evidence 2.9 to 3.8, Efficacy 3.0 to 3.6 | 7.2 / 10 💪 Strong recommend |
| A clear clinical immune outcome (fewer infections) replicates the NK and IgA marker data | Breadth 3.5 to 4.0, Evidence 2.9 to 3.3 | 6.9 / 10 👍 Worth trying |
| Toxin-binding confirmed for a broader set of pollutants in repeat human trials | Efficacy 3.0 to 3.3, Breadth 3.5 to 3.8 | 6.8 / 10 👍 Worth trying |
| Larger trials replicate the neutral Pinto-Leite cardiovascular result | Efficacy 3.0 to 2.4, Evidence 2.9 to 2.4 | 5.9 / 10 👍 Worth trying |
| Heavy-metal contamination shown to be intrinsic and unavoidable, not a sourcing issue | Safety 1.7 to 2.6, Evidence 2.9 to 2.5 | 5.6 / 10 ⚖️ Neutral |
| Both a neutral large trial and persistent contamination concerns emerge | Efficacy 3.0 to 2.3, Evidence 2.9 to 2.3, Safety 1.7 to 2.4 | 5.2 / 10 ⚖️ Neutral |
Key Evidence Sources
- Fallah AA et al. 2018 - Effect of Chlorella supplementation on cardiovascular risk factors: A meta-analysis of randomized controlled trials, Clinical Nutrition. Meta-analysis of 19 RCTs (n=797): total cholesterol -9.09 mg/dL, LDL -8.32 mg/dL, systolic BP -4.51 mmHg, fasting glucose -4.23 mg/dL; flagship cardiovascular evidence.
- Yarmohammadi S et al. 2021 - Effect of Chlorella vulgaris on Liver Function Biomarkers: a Systematic Review and Meta-Analysis, Clinical Nutrition Research. Meta-analysis of 8 RCTs: AST fell 9.15 U/L (95% CI -16.09 to -2.21, significant); ALT and ALP nonsignificant; anchors the liver-enzyme case.
- Ebrahimi-Mameghani M et al. 2014 - The Effect of Chlorella vulgaris Supplementation on Liver Enzymes, Serum Glucose and Lipid Profile in NAFLD, Health Promotion Perspectives. NAFLD RCT (n=55), 1.2 g/day plus vitamin E for 8 weeks: ALT fell 13.2 IU/L vs 5.73 placebo, with AST and ALP also reduced.
- Pinto-Leite C et al. 2025 - Chlorella and Spirulina as Adjuvants of Cardiovascular Risk Factor Control: A Systematic Review and Meta-Analysis of RCTs, Nutrients. Review of 12 chlorella studies finding a NEUTRAL pooled effect on blood pressure and lipids; included as the honest dissenting heterogeneity result.
- Kwak JH et al. 2012 - Beneficial immunostimulatory effect of short-term Chlorella supplementation: NK cell activity and early inflammatory response, Nutrition Journal. RCT (n=51), 5 g/day for 8 weeks: natural-killer-cell activity rose significantly, with IFN-gamma and IL-1beta also increased versus placebo.
- Otsuki T et al. 2011 - Salivary secretory immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived supplement, Nutrition Journal. Crossover RCT (n=15 men): salivary secretory IgA concentration and secretion rate rose vs baseline and placebo.
- Halperin SA et al. 2003 - Safety and immunoenhancing effect of a Chlorella-derived supplement in healthy adults undergoing influenza vaccination: RCT, CMAJ. Double-blind RCT (n=124): NO overall vaccine antibody benefit, only a younger subgroup responded; the honest negative immune result and a key safety datapoint.
- Nakano S et al. 2007 - Chlorella pyrenoidosa supplementation decreases dioxin and increases IgA concentrations in breast milk, Journal of Medicinal Food. Trial in 35 pregnant women (6 g/day): breast-milk dioxin toxic-equivalents significantly lower (P=0.003), milk IgA higher (P=0.03); anchors the toxin-binding case.
- Zempo-Miyaki A et al. 2017 - Effect of Chlorella-derived multicomponent supplementation on maximal oxygen uptake and serum vitamin B2 in young men, Journal of Clinical Biochemistry and Nutrition. Trial (n=34), 6 g/day for 4 weeks: VO2max rose 42.1 to 44.9 mL/kg/min with no change in placebo; small, multi-ingredient product.
- Merchant RE et al. 2015 - Nutritional Supplementation with Chlorella pyrenoidosa Lowers Serum Methylmalonic Acid in Vegans and Vegetarians, Journal of Medicinal Food. Open-label study (n=17), 9 g/day: serum methylmalonic acid fell 441 to 301 nmol/L at 30 days, with 88% showing >10% reduction; supports bioactive B12 (small, not an RCT).
- Shiri E et al. 2025 - Chlorella supplementation diminishes cardiovascular risk factors in adults: A GRADE-assessed systematic review and meta-analysis of RCTs, Algal Research. GRADE-assessed systematic review reporting directional reductions in total cholesterol, LDL, blood pressure, BMI, and hs-CRP; reinforces the cardiovascular signal alongside Fallah 2018.
- Chlorella - Wikidata entity Q133017 (genus of edible freshwater green algae). Canonical entity record for the Chlorella genus, used for JSON-LD entity linking; described by Beijerinck 1890.
What does the evidence say about Chlorella?
Evidence on this intervention is summarized across three complementary streams: contemporary clinical research, pre-RCT-era pharmacology and observational use, and the traditional medical systems that documented it first. Convergence across streams signals higher confidence; divergence is surfaced honestly.
Modern Clinical Research
Confidence: Medium
Citations: Fallah 2018, Yarmohammadi 2021, Ebrahimi-Mameghani 2014, Pinto-Leite 2025, Kwak 2012, Otsuki 2011, Halperin 2003, Nakano 2007
Traditional Medicine Systems
Confidence: Limited
Citations: Merchant 2015, Nakano 2007
Holistic Evidence for Chlorella
Modern trials and decades of East Asian food use agree on the same modest picture: chlorella is a safe, broadly nutritious whole food with real but small cardiovascular and liver effects, best judged by personal bloodwork rather than marketing.
What to Track If You Try This
These are the data points that matter most while running a 30-day Experiment with this intervention.
How to read this section
- Pre
- Test or score before starting the protocol. Anchors a baseline.
- During
- Track while running the protocol so you can see if anything is changing.
- Post
- Re-test after a full cycle to confirm the change held.
- Up
- The marker should rise. For most positive outcomes, that is a good sign.
- Down
- The marker should fall. For most positive outcomes, that is a good sign.
- Stable
- The marker should hold steady. Big swings in either direction are a yellow flag.
- Watch
- Direction depends on dose, timing, and your baseline. Pay close attention to the trend.
- N/A
- No expected direction. The entry is there to anchor a baseline reading.
- Primary
- The Pulse dimension most likely to shift. Track this first.
- Secondary
- Also relevant, but a smaller or less consistent shift. Track if Primary is unclear.
Bloodwork to Order
Open These Markers In Your Dashboard
- LDL Cholesterol Pre | Expected Down
- Total Cholesterol Post | Expected Down
- ALT Post | Expected Down
- Blood Pressure During | Expected Down
- Ferritin Post | Expected Up
Pulse Dimensions to Watch
- Energy During | Expected Watch | Secondary
- Body During | Expected Watch | Primary
Subjective Signals (Daily Voice Card)
- Digestive comfort (bloating, gas, looser stool) Scale 1-5 | During | Expected Watch
- Green stool color (harmless chlorophyll marker that confirms intake) Scale 1-5 | During | Expected Watch
Red Flags: Stop and Consult
- New rash or sun-triggered skin reaction (possible photosensitivity); stop and reassess.
- Persistent severe GI distress beyond the first two weeks rather than a settling adjustment.
- Product with no heavy-metal certificate of analysis; switch sources before continuing.
Other interventions for Cardiovascular
See all ratings →📊 How BioHarmony scoring works
BioHarmony translates a weighted expected-value calculation into a reader-facing 0–10 score. Tier bands: Skip 0–2.9, Caution 3.0–4.4, Neutral 4.5–5.7, Worth Trying 5.8–6.9, Strong Recommend 7.0–8.7, Top-tier 8.8–10.0.
Harm-type downsides (safety risk, side effects, reversibility, dependency) carry a 1.4× precautionary multiplier. Harm weighs more than benefit. Opportunity-type downsides (financial cost, time/effort, opportunity cost) are subtracted at face value.
Use case subratings are independent assessments of how well the intervention addresses specific health goals. They are not components of the overall score. Each subrating reflects the scorer's judgment based on use-case-specific evidence, safety, and effect sizes.
Every dimension is evaluated on a 1–5 scale, and the baseline (1) is subtracted before weighting. A perfect intervention with zero downsides contributes zero penalty rather than a residual floor, so top-tier scores are actually reachable.
EV = Upside − Downside
EV = 1.995 − 0.816 = 1.179
Formula v2.0 maps EV = 0 to score 5.0. Above neutral, EV = +4.00 reaches 10.0; below neutral, EV = −5.36 reaches 0.0. Both sides use the full 5-point half-scale.
Score = 5 + (1.179 / 4.00) × 5 = 6.5 / 10
